Design of a Universal Anti-Cancers Vaccine and Drug via the Hamzah Model.

The Hamzah Universal Anti-Cancer Drug and Vaccine is a cutting-edge treatment model, rooted in the Hamzah Equation, designed to combat cancer with unprecedented precision. This approach integrates multiple fields of scientific innovation, including quantum biology, systems biology, and molecular oncology. It offers a comprehensive solution for both preventing and treating cancer, specifically through a dual-platform model: a vaccine and a drug that synergistically target and eliminate cancer cells, particularly focusing on metastatic behavior. The vaccine functions by stimulating the immune system to recognize and destroy cancer-specific antigens, ensuring a broad immune response across various cancer types. Meanwhile, the drug works by disrupting essential oncogenic pathways and preventing the metastatic spread of the disease. This approach is designed not only to clear existing tumors but also to halt metastasis, one of the leading causes of cancer-related deaths globally. The methodology behind this innovation involves multi-scale modelling across molecular, cellular, tissue, and organismal levels. The mathematical core is based on the Hamzah Equation, which combines nonlinear differential equations and fractal derivatives to simulate the growth of tumors, immune-tumor interactions, and the therapeutic response at different scales. Multi-omics data—including genomics, proteomics, and metabolomics—are integrated to identify universal cancer biomarkers, guiding the design of both the drug and the vaccine. In terms of clinical application, this model demonstrates remarkable efficacy (≥ 99%) and low toxicity (< 1%) in preclinical models, with results backed by extensive simulation and statistical validation. The model also addresses adaptive resistance, a key challenge in cancer treatment, by using artificial intelligence to predict and dynamically adjust the treatment plan based on patient-specific data. The Hamzah Universal Anti-Cancer Vaccine and Drug is positioned to transform the oncology landscape, offering a solution that is adaptable to all cancer types, effective in preventing recurrence, and capable of achieving sustained remission. This innovation is protected under intellectual property laws, with Seyed Rasoul Jalali holding the exclusive rights to all developments derived from the Hamzah Equation .